Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Seow

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Elife|May 19, 2022
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodiesCeri Alan Fielding, Pragati Sabberwal, James C Williamson, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
International Journal of Obesity (2005)|May 19, 2022
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19Julia S El-Sayed Moustafa, Anne U Jackson, Sarah M Brotman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
Science Advances|April 23, 2021
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Elife|May 19, 2022
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodiesCeri Alan Fielding, Pragati Sabberwal, James C Williamson, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
The Journal of Infection|October 17, 2020
Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE EnglandPhilippa M Wells, Katie J Doores, Simon Couvreur, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
International Journal of Obesity (2005)|May 19, 2022
ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition-implications for COVID-19Julia S El-Sayed Moustafa, Anne U Jackson, Sarah M Brotman, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
Science Advances|April 23, 2021
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Pageof 5